Shanghai Guangsheng Industrial

Shanghai Guangsheng Industrial is a prominent Chinese healthcare conglomerate and holding company, primarily recognized as the controlling shareholder of Fujian Cosunter Pharmaceutical (formerly known as Fujian Guangsheng Biology). The company maintains a diverse portfolio that spans medical devices, consumer health products, and innovative drug development. Through its pharmaceutical subsidiaries, it focuses on the research and commercialization of treatments for liver diseases, particularly chronic Hepatitis B, and has recently expanded into anti-viral therapies for COVID-19. Shanghai Guangsheng Industrial is headquartered in Shanghai and serves as the strategic hub for the Guangsheng Group's extensive operations in the life sciences sector. The company is also well-known for its Great Wall brand of medical consumables and health products, and it manages a robust pipeline of small molecule candidates targeting viral infections and oncology.